Literature DB >> 16119173

[Carcinosarcoma of the pancreas--case report and literature review].

Bogdan Chmiel1, Anatol Wodołazski, Anna Kozaczka.   

Abstract

Forty seven year old man underwent laparotomy because of obstructive jaundice. As a cause of biliary tree obstruction a tumor of the head of the pancreas was diagnosed. Pancreatoduodenectomy was performed. Within removed specimen by histologic examination a malignant tumor with adenocarcinoma and leyosarcoma parts was diagnosed. Mesenchymal component immunohistochemically were strongly and diffusely reactive for antibodies to vimentin and actin, weak and focal for EMA. There was no reactivity to cytokeratin. Opposite, the epithelial component of the tumor revealed strong reaction to cytokeratin and EMA, but weak to vimentin and actin. To our knowledge it is twelfth case of carcinosarcoma of the pancreas confirmed immunohistochemically in the literature.

Entities:  

Mesh:

Year:  2005        PMID: 16119173

Source DB:  PubMed          Journal:  Wiad Lek        ISSN: 0043-5147


  4 in total

1.  Carcinosarcoma colliding osteosarcoma of the pancreas: a rare case report of multiple clonal originated pancreatic tumors.

Authors:  Xingang Zhou; Man Li; Peng Wang; Xiaoying Teng; Lei Sun; Jiamin Chen; Zhe Jia
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Primary splenic carcinosarcoma with local invasion of chest wall: a rare case.

Authors:  Ting Sun; Gui-Feng Wang; Yun Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Aug.       Impact factor: 3.066

Review 3.  Pancreatic carcinosarcoma with rare long-term survival: Case report and review of the literature.

Authors:  Zhe Jia; Ke Zhang; RongHai Huang; XinGang Zhou; Li Jiang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 4.  Pancreatic carcinosarcoma mimics malignant intraductal papillary mucinous neoplasm: A rare case report and literature review.

Authors:  Bing-Qi Li; Qiao-Fei Liu; Xiao-Yan Chang; Ya Hu; Jie Chen; Jun-Chao Guo
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.